alosetron has been researched along with Intestinal Neoplasms in 1 studies
alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.
Intestinal Neoplasms: Tumors or cancer of the INTESTINES.
Excerpt | Relevance | Reference |
---|---|---|
"In 27 patients with carcinoid diarrhoea, symptoms were recorded daily and gastrointestinal transit was measured by scintigraphy in a three dose (0." | 2.69 | Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. ( Burton, DD; Camilleri, M; Forstrom, LA; Pitot, HC; Rubin, J; Saslow, SB; Scolapio, JS; Thomforde, GM; Zinsmeister, AR, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saslow, SB | 1 |
Scolapio, JS | 1 |
Camilleri, M | 1 |
Forstrom, LA | 1 |
Thomforde, GM | 1 |
Burton, DD | 1 |
Rubin, J | 1 |
Pitot, HC | 1 |
Zinsmeister, AR | 1 |
1 trial available for alosetron and Intestinal Neoplasms
Article | Year |
---|---|
Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.
Topics: Adult; Aged; Aged, 80 and over; Carbolines; Carcinoid Tumor; Colon; Diarrhea; Double-Blind Method; D | 1998 |